Against the record
Liberty, from Microbot Medical, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 13 April 2026: After a limited launch, Microbot put Liberty on full sale in the US. Uses include treating fibroids, enlarged prostate and knee pain by blocking small arteries.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
Drive The Future of Intervention™ LIBERTY® is the only FDA cleared, single-use, remotely operated robotic system for peripheral endovascular procedures, and it is designed for precise vascular navigation while aiming to reduce radiation exposure and physical strain.
Written by Microbot Medical on YouTube.
